Terlipressin: An Asset for Hepatologists!SARIN, S. K; SHARMA, Praveen.Hepatology (Baltimore, Md.). 2011, Vol 54, Num 2, pp 724-728, issn 0270-9139, 5 p.Article

Cutaneous Necrosis Secondary to Terlipressin TherapyPOSADA, Celia; FEAL, Carlos; GARCIA-CRUZ, Arunzazu et al.Acta dermato-venereologica. 2009, Vol 89, Num 4, pp 434-435, issn 0001-5555, 2 p.Article

Vasopressin and terlipressin: pharmacology and its clinical relevanceKAM, P. C. A; WILLIAMS, S; YOONG, F. F. Y et al.Anaesthesia. 2004, Vol 59, Num 10, pp 993-1001, issn 0003-2409, 9 p.Article

Terlipressin-Induced Skin Necrosis and RhabdomvolvsisZIMMER, Vincent; LAMMERT, Frank.The American journal of the medical sciences (Print). 2010, Vol 340, Num 6, issn 0002-9629, p. 506Article

Future indications for terlipressin therapy. DiscussionLEBREC, D.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 3, pp 65-68, issn 0953-0673, 4 p.Conference Paper

Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysisPOLITO, Angelo; PARISINI, Emilio; RICCI, Zaccaria et al.Intensive care medicine (Print). 2012, Vol 38, Num 1, pp 9-19, issn 0342-4642, 11 p.Article

Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shockMORELLI, Andrea; ROCCO, Monica; CONTI, Giorgio et al.Intensive care medicine (Print). 2004, Vol 30, Num 4, pp 597-604, issn 0342-4642, 8 p.Article

The Effect of Terlipressin on Hepatic Hemodynamics in Small-For-Size LiversZUHAI REN; YONG XU; SHAIHONG ZHU et al.Hepato-gastroenterology. 2012, Vol 59, Num 113, pp 208-211, issn 0172-6390, 4 p.Article

Le syndrome hépatorénal: mise au point = Hepatorenal syndrome: FocusGUEUTIN, Victor; MEFTAH, Aimele; DESBUISSONS, Geoffroy et al.Néphrologie & thérapeutique. 2013, Vol 9, Num 7, pp 471-480, issn 1769-7255, 10 p.Article

Somatostatine: propriétés et place dans le traitement de l'hémorragie digestiveTHABUT, D; LEMOINNE, S; RUDLER, M et al.Annales françaises de médecine d'urgence. 2012, Vol 2, Num 3, issn 2108-6524, S8-S13, SUP1Article

Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosisKRAG, Aleksander; BENDTSEN, Flemming; MORTENSEN, Christian et al.European journal of gastroenterology & hepatology. 2010, Vol 22, Num 9, pp 1085-1092, issn 0954-691X, 8 p.Article

Long-term outcome of patients treated with terlipressin for types 1 and 2 hepatorenal syndromeTESTRO, Adam G; WONGSEELASHOTE, Sarah; ANGUS, Peter W et al.Journal of gastroenterology and hepatology. 2008, Vol 23, Num 10, pp 1535-1540, issn 0815-9319, 6 p.Article

The Efficacy of Terlipressin in Comparison with Albumin in the Prevention of Circulatory Changes after the Paracentesis of Tense Ascites : a Randomized Multicentric StudyLATA, Jan; MARECEK, Zdenek; TOZZI, Igor et al.Hepato-gastroenterology. 2007, Vol 54, Num 79, pp 1930-1933, issn 0172-6390, 4 p.Article

Terlipressin as an adjunct vasopressor in refractory hypotension after tricyclic antidepressant intoxicationZUIDEMA, Xander; DÜNSER, Martin W; WENZEL, Volker et al.Resuscitation. 2007, Vol 72, Num 2, pp 319-323, issn 0300-9572, 5 p.Article

terlipressine ^{(Glypressine°)} syndrome hépatorénal de type I : Un délai plus long pour organiser une transplantation hépatique = Terlipressin for type 1 hepatorenal syndrome : allows a longer delay for organisation of hepatic transplantationLa Revue Prescrire. 2006, Vol 26, Num 274, pp 491-491, issn 0247-7750, 1 p.Article

Hepatorenal syndrome : A dreaded complication of end-stage liver diseaseCARDENAS, Andrés.The American journal of gastroenterology. 2005, Vol 100, Num 2, pp 460-467, issn 0002-9270, 8 p.Article

Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: Effects on systemic and regional hemodynamicsMORELLI, Andrea; TRITAPEPE, Luigi; ROCCO, Monica et al.Anesthesiology (Philadelphia). 2005, Vol 102, Num 1, pp 12-19, issn 0003-3022, 8 p.Article

Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: Pilot studyTHERAPONDOS, George; STANLEY, Adrian J; HAYES, Peter C et al.Journal of gastroenterology and hepatology. 2004, Vol 19, Num 1, pp 73-77, issn 0815-9319, 5 p.Article

Use of color Doppler EUS in assessing azygos blood flow for patients with portal hypertensionYUK TONG LEE; SUNG, J. J. Y; MAN YEE YUNG et al.Gastrointestinal endoscopy. 1999, Vol 50, Num 1, pp 47-52, issn 0016-5107Conference Paper

Rupture des varices œsophagiennes : les médicaments des traitements curatifs et prophylactiques = Œsoplageal varices bleeding : curative and prophylactic drugsBRANDISSOU, S; MORENA, C; BOURGAUX, J.-F et al.Journal de pharmacie clinique (Paris). 1998, Vol 17, Num 1, pp 7-15, issn 0291-1981Article

Comment je traite pharmacologiquement les hémorragies digestives de l'hypertension portale en 1998 = How to treat, pharmacologicaly digestive haemorrhages due to portal hypertension in 1998LEBREC, D.Médecine et chirurgie digestives (Paris). 1998, Vol 27, Num 1, pp 5-6, issn 0047-6412Conference Paper

Hémorragies digestives hautes chez les malades atteints de cirrhose - II = Upper digestive tract bleeding in cirrhotic patientsMOREAU, R; SOUPISON, T; VACHIERY, F et al.Concours médical (Paris). 1997, Vol 119, Num 5, pp 302-304, issn 0010-5309Article

The role of pharmaco-therapy for acute variceal haemorrhage in the era of endoscopic haemostasisCHAN, L. Y; SUNG, J. J. Y.Alimentary pharmacology & therapeutics. 1997, Vol 11, Num 1, pp 45-50, issn 0269-2813Article

Time profile of the haemodynamic effects of terlipressin in portal hypertensionESCORSELL, A; BANDI, J. C; MOITINHO, E et al.Journal of hepatology. 1997, Vol 26, Num 3, pp 621-627, issn 0168-8278Article

Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive ratsHUANG, Y.-T; TSAI, J.-F; LIN, H.-C et al.Canadian journal of physiology and pharmacology. 1997, Vol 75, Num 10-11, pp 1220-1225, issn 0008-4212Article